Stock IIQ INOVIQ LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials INOVIQ Ltd

Equities

IIQ

AU0000196149

Biotechnology & Medical Research

Delayed Australian S.E.
Other stock markets
 01:27:22 2024-06-06 am EDT 		5-day change 1st Jan Change
0.565 AUD +1.80% Intraday chart for INOVIQ Ltd -13.08% -15.04%
Jun. 07 Inoviq Requests Trading Halt MT
Apr. 19 INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test MT

Valuation

Fiscal Period: June 2023 2024 2025 2026
Capitalization 1 78.22 51.99 - -
Enterprise Value (EV) 1 78.22 44.89 43.09 45.39
P/E ratio -8.72 x -5.77 x -7.53 x -17.7 x
Yield - - - -
Capitalization / Revenue - 57.8 x 32.5 x 6.34 x
EV / Revenue - 49.9 x 26.9 x 5.54 x
EV / EBITDA - -5.83 x -6.07 x -16.8 x
EV / FCF - -5.47 x -5.9 x -15.7 x
FCF Yield - -18.3% -16.9% -6.39%
Price to Book - 2.83 x 2.83 x 5.65 x
Nbr of stocks (in thousands) 92,019 92,019 - -
Reference price 2 0.8500 0.5650 0.5650 0.5650
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2023 2024 2025 2026
Net sales 1 - 0.9 1.6 8.2
EBITDA 1 - -7.7 -7.1 -2.7
EBIT 1 - -9 -8.4 -3.9
Operating Margin - -1,000% -525% -47.56%
Earnings before Tax (EBT) 1 - -9 -8.4 -3.9
Net income 1 -8.969 -9 -8.4 -3.9
Net margin - -1,000% -525% -47.56%
EPS 2 -0.0975 -0.0980 -0.0750 -0.0320
Free Cash Flow 1 - -8.2 -7.3 -2.9
FCF margin - -911.11% -456.25% -35.37%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 7.1 8.9 6.6
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - -8.2 -7.3 -2.9
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 0.2000 0.2000 0.1000
Cash Flow per Share 2 - -0.0700 -0.0600 -0.0200
Capex 1 - 0.5 0.2 0.2
Capex / Sales - 55.56% 12.5% 2.44%
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
INOVIQ LTD Stock INOVIQ Ltd
-15.04% 34.34M
MODERNA, INC. Stock Moderna, Inc.
+49.41% 56.95B
LONZA GROUP AG Stock Lonza Group AG
+41.65% 40.26B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.72% 39.32B
CELLTRION, INC. Stock Celltrion, Inc.
-5.96% 28.37B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.99% 26.45B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-19.82% 19.41B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.35% 12.54B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-0.08% 12.15B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.18% 12.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. IIQ Stock
  4. Financials INOVIQ Ltd